Avecho Biotechnology Limited (ASX:AVE)
Australia
· Delayed Price · Currency is AUD
0.0110
-0.0010 (-8.33%)
Mar 10, 2026, 11:00 AM AEST
Avecho Biotechnology Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -4.42 | -3.12 | -3.44 | -2.34 | -3.42 | |
| Depreciation & Amortization | 0.14 | 0.14 | 0.18 | 0.23 | 0.43 | |
| Stock-Based Compensation | 0.39 | 0.01 | 0.1 | 0.2 | 0.53 | |
| Provision & Write-off of Bad Debts | - | - | -0 | -0.02 | 0.05 | |
| Other Operating Activities | 0.06 | 0.05 | 0.37 | - | - | |
| Change in Accounts Receivable | 0.04 | -1.15 | -0.35 | 0.4 | -0.67 | |
| Change in Inventory | 0.13 | -0.04 | -0.06 | -0.21 | -0.1 | |
| Change in Accounts Payable | -0.01 | 0.03 | -0.09 | 0.03 | 0.03 | |
| Change in Unearned Revenue | 4.83 | -0.16 | 0.16 | - | - | |
| Change in Other Net Operating Assets | -0.07 | 0.26 | -0.04 | 0.04 | 0.04 | |
| Operating Cash Flow | 1.1 | -3.97 | -3.18 | -1.67 | -3.1 | |
| Capital Expenditures | - | - | - | -0.05 | -0.2 | |
| Other Investing Activities | - | -0.02 | - | - | - | |
| Investing Cash Flow | - | -0.02 | - | -0.05 | -0.2 | |
| Long-Term Debt Issued | - | 0.93 | - | - | - | |
| Long-Term Debt Repaid | -1.13 | -0.08 | -0.07 | -0.08 | -0.07 | |
| Net Debt Issued (Repaid) | -1.13 | 0.85 | -0.07 | -0.08 | -0.07 | |
| Issuance of Common Stock | 2.5 | - | 8 | 0 | 5.06 | |
| Other Financing Activities | -0.19 | - | -0.72 | - | -0.29 | |
| Financing Cash Flow | 1.19 | 0.85 | 7.22 | -0.08 | 4.69 | |
| Net Cash Flow | 2.29 | -3.13 | 4.04 | -1.8 | 1.39 | |
| Free Cash Flow | 1.1 | -3.97 | -3.18 | -1.72 | -3.3 | |
| Free Cash Flow Margin | 89.12% | -350.38% | -671.51% | -152.16% | -416.01% | |
| Free Cash Flow Per Share | - | -0.00 | -0.00 | -0.00 | -0.00 | |
| Cash Interest Paid | 0 | 0.01 | 0.01 | 0 | 0.01 | |
| Cash Income Tax Paid | -1.7 | -1.07 | -0.72 | -1.04 | - | |
| Levered Free Cash Flow | -2.14 | -2.85 | -1.89 | -0.86 | -1.99 | |
| Unlevered Free Cash Flow | -1.85 | -2.81 | -1.88 | -0.86 | -1.99 | |
| Change in Working Capital | 4.92 | -1.05 | -0.39 | 0.27 | -0.69 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.